Skip to Content
Merck
  • Molecular encapsulation of 5-nitroindazole derivatives in 2,6-dimethyl-beta-cyclodextrin: electrochemical and spectroscopic studies.

Molecular encapsulation of 5-nitroindazole derivatives in 2,6-dimethyl-beta-cyclodextrin: electrochemical and spectroscopic studies.

Bioorganic & medicinal chemistry (2009-05-26)
Fernanda Pérez-Cruz, Carolina Jullian, Jorge Rodriguez, Vicente J Arán, Claudio Olea-Azar
ABSTRACT

Four different 5-nitroindazole derivatives (1-4) and its inclusion with Heptakis(2,6-di-O-methyl)-beta-cyclodextrin (DMbetaCD) were investigated. The stoichiometric ratios and stability constants describing the extent of formation of the complexes were determined by phase-solubility measurements obtaining in all cases a type-A(L) diagram. Also electrochemical studies were carried out, where the observed change in the E(PC) value indicated a lower feasibility of the nitro group reduction. The same behavior was observed in the ESR studies. The detailed spatial configuration is proposed based on 2D NMR methods. These results are further interpreted using molecular modeling studies. The latter results are in good agreement with the experimental data.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Heptakis(2,6-di-O-methyl)-β-cyclodextrin
SKU
Pack Size
Availability
Price
Quantity